These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


387 related items for PubMed ID: 24116913

  • 21. Pharmaceutically used polymers: principles, structures, and applications of pharmaceutical delivery systems.
    Khandare J, Haag R.
    Handb Exp Pharmacol; 2010; (197):221-50. PubMed ID: 20217532
    [Abstract] [Full Text] [Related]

  • 22. A common profile for polymer-based controlled releases and its logical interpretation to general release process.
    Li S, Shen Y, Li W, Hao X.
    J Pharm Pharm Sci; 2006; 9(2):238-44. PubMed ID: 16959193
    [Abstract] [Full Text] [Related]

  • 23. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action.
    Henkin RI.
    Nutrition; 2010 Jan; 26(1):33-9. PubMed ID: 20005465
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Challenges of therapeutic delivery using conducting polymers.
    Poole-Warren L, Goding J.
    Ther Deliv; 2012 Apr; 3(4):421-7. PubMed ID: 22834074
    [No Abstract] [Full Text] [Related]

  • 26. The design of pH-sensitive chitosan-based formulations for gastrointestinal delivery.
    Du H, Liu M, Yang X, Zhai G.
    Drug Discov Today; 2015 Aug; 20(8):1004-11. PubMed ID: 25769687
    [Abstract] [Full Text] [Related]

  • 27. Photoresponsive hydrogels for biomedical applications.
    Tomatsu I, Peng K, Kros A.
    Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1257-66. PubMed ID: 21745509
    [Abstract] [Full Text] [Related]

  • 28. Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics.
    Nakamura K, Murray RJ, Joseph JI, Peppas NA, Morishita M, Lowman AM.
    J Control Release; 2004 Mar 24; 95(3):589-99. PubMed ID: 15023469
    [Abstract] [Full Text] [Related]

  • 29. Inhalative nanomedicine--opportunities and challenges.
    Bur M, Henning A, Hein S, Schneider M, Lehr CM.
    Inhal Toxicol; 2009 Jul 24; 21 Suppl 1():137-43. PubMed ID: 19558246
    [Abstract] [Full Text] [Related]

  • 30. Formulation strategy and use of excipients in pulmonary drug delivery.
    Pilcer G, Amighi K.
    Int J Pharm; 2010 Jun 15; 392(1-2):1-19. PubMed ID: 20223286
    [Abstract] [Full Text] [Related]

  • 31. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery.
    Sakagami M.
    Adv Drug Deliv Rev; 2006 Oct 31; 58(9-10):1030-60. PubMed ID: 17010473
    [Abstract] [Full Text] [Related]

  • 32. Controlled Release Inhalable Polymeric Microspheres for Treatment of Pulmonary Arterial Hypertension.
    Saigal A, Ng WK, Tan RB, Chan SY.
    Curr Pharm Des; 2015 Oct 31; 21(40):5868-76. PubMed ID: 26446472
    [Abstract] [Full Text] [Related]

  • 33. Long acting porous microparticle for pulmonary protein delivery.
    Kwon MJ, Bae JH, Kim JJ, Na K, Lee ES.
    Int J Pharm; 2007 Mar 21; 333(1-2):5-9. PubMed ID: 17296275
    [Abstract] [Full Text] [Related]

  • 34. Molecularly imprinted polymers as the future drug delivery devices.
    Luliński P.
    Acta Pol Pharm; 2013 Mar 21; 70(4):601-9. PubMed ID: 23923384
    [Abstract] [Full Text] [Related]

  • 35. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS, Quadir MA, Haider SS.
    J Pharm Pharm Sci; 2003 Mar 21; 6(2):282-91. PubMed ID: 12935440
    [Abstract] [Full Text] [Related]

  • 36. Hydrogels as drug-delivery platforms: physicochemical barriers and solutions.
    Alkayyali LB, Abu-Diak OA, Andrews GP, Jones DS.
    Ther Deliv; 2012 Jun 21; 3(6):775-86. PubMed ID: 22838072
    [Abstract] [Full Text] [Related]

  • 37. Controlling the release of proteins/peptides via the pulmonary route.
    Shoyele SA.
    Methods Mol Biol; 2008 Jun 21; 437():141-8. PubMed ID: 18369966
    [Abstract] [Full Text] [Related]

  • 38. 3-dimensional (3D) fabricated polymer based drug delivery systems.
    Moulton SE, Wallace GG.
    J Control Release; 2014 Nov 10; 193():27-34. PubMed ID: 25020039
    [Abstract] [Full Text] [Related]

  • 39. Layer-by-layer assembly of multilayer films for controlled drug release.
    Choi D, Hong J.
    Arch Pharm Res; 2014 Jan 10; 37(1):79-87. PubMed ID: 24277693
    [Abstract] [Full Text] [Related]

  • 40. Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications.
    Jaspart S, Piel G, Delattre L, Evrard B.
    Expert Opin Drug Deliv; 2005 Jan 10; 2(1):75-87. PubMed ID: 16296736
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 20.